Concepedia

Author

Andreas Machl

Ono Pharmaceutical (United States)

Also Known As

Andreas Machl, Andreas W Machl, Andreas W. Machl

21

Publications

384

Citations

10

H-Index

28

Concepts

All Affiliations

Ono Pharmaceutical (United States)Merck (Germany)Research & Development InstituteNational Institutes of HealthNational Cancer Institute
AM

About

Andreas Machl is an author at Ono Pharmaceutical (United States) specializing in medicine, cell biology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

179

2

Cell Biology

3

3

127

3

Natural Sciences

2

2

62

4

Biochemistry

1

1

52

5

Cellular Physiology

1

1

86

Andreas Machl

×

9

Publications

340

Citations

9

H-Index

YearCitations

SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily

Karen Swisshelm, Andreas Machl, Simone A Planitzer,

Gene

1999

86

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Byoung Chul Cho, Jong Seok Lee, Yi‐Long Wu,

Journal of Thoracic Oncology

2023

71

Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters

Seong A. Kang, David J. O’Neill, Andreas Machl,

Cell chemical biology

2019

52

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Changhoon Yoo, Milind Javle, Helena Verdaguer Mata,

Hepatology

2023

44

M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier.

Andreas Machl, Erik Wilker, Hui Tian,

PubMed

2016

31

Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial

Alexander I. Spira, M. S. Wertheim, Edward Kim,

The Oncologist

2022

23

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Arun Rajan, Houssein Abdul Sater, Osama E. Rahma,

Journal for ImmunoTherapy of Cancer

2024

12

Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers

Lizbeth DeSelm, Bayard R. Huck, Ruoxi Lan,

Journal of Medicinal Chemistry

2021

11

Identification of a novel c-DNA overexpressed in Fanconi's anemia fibroblasts partially homologous to a putative l-3-phosphoserine-phosphatase

Simone A Planitzer, Andreas Machl, Markus Rueckels,

Gene

1998

10

Page 1